Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
61.34
-1.96 (-3.10%)
At close: Aug 20, 2026, 4:00 PM EDT
61.61
+0.27 (0.44%)
Pre-market: Aug 21, 2026, 7:16 AM EDT
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$2,099,134
Market Cap
9.13B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| ImmunityBio | 691 |
| Crinetics Pharmaceuticals | 594 |
| Immunovant | 315 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
PCVX News
- 15 days ago - Vaxcyte reports Q2 EPS ($1.97), consensus ($2.10) - TheFly
- 15 days ago - Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Vaxcyte Slides: Investor presentation - Filings
- 16 days ago - Vaxcyte Quarterly report: Q2 2026 - Filings
- 16 days ago - Vaxcyte Earnings release: Q2 2026 - Filings
- 6 weeks ago - Vaxcyte to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Vaxcyte Transcript: AGM 2026 - Transcripts
- 2 months ago - Vaxcyte Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts